Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | -1.01% | +8.84% | -86.62% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.62% | 134M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.93% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+6.22% | 8.83B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- SVB Securities Adjusts Amylyx Pharmaceuticals' Price Target to $50 from $31, Maintains Outperform Rating